Palonosetron Injection
Product Images NDC 67184-0514

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Palonosetron (NDC 67184-0514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Palonosetron Hydrochloride (Palonosetron 1)

Chemical structure of Palonosetron Hydrochloride depicting the molecular framework including fused rings and hydrochloride (HCl) component.*

FDA Label Image

Palonosetron-02 (Palonosetron 2)

A horizontal bar chart depicting differences in complete response rates with error bars labeled as percentages. The x-axis ranges from -10 to 35, showing varying response rates with intervals including [2%, 23%], [-2%, 22%], and [-9%, 13%]. No specific drug names or study details are visible in the image.*

FDA Label Image

Palonosetron-03 (Palonosetron 3)

A scatter plot graph depicting differences in complete response rates, with data points labeled [3%, 27%] and [8%, 30%]. The x-axis measures the difference in complete response rates, ranging from -10 to 35. No additional clinical details are shown.*

FDA Label Image

Palonosetron-04 (Palonosetron 4)

A horizontal bar chart showing differences in complete response rates with confidence intervals, plotted along an axis ranging roughly from -10 to 35%. Two data points display percentages with confidence intervals: one near 7% and 31%, and another near 0% and 24%. This figure visually compares response rate differences for Palonosetron injection.*

FDA Label Image

Container Label Ndc 67184-0515-1 (Palonosetron 5)

Palonosetron HCl Injection label showing a 0.075 mg/1.5 mL strength for intravenous injection. The single-dose vial contains 1.5 mL sterile solution. Manufacturer is Qilu Pharmaceutical (Hainan) Co., Ltd., and it is made for Apotex Corp. Storage instructions indicate keeping between 20°C to 25°C and protecting from light. The label includes space for lot and expiration dates, along with the NDC 67184-0515-1 and a barcode.*

FDA Label Image

Carton Label Ndc 67184-0515-2 (Palonosetron 6)

Palonosetron HCl Injection 0.075 mg/1.5 mL (0.05 mg/mL) label for intravenous injection. The label indicates it contains five 1.5 mL single-dose sterile vials. Manufactured by Qilu Pharmaceutical Co., Ltd., Haikou, China, and for Apotex Corp., Weston, Florida, USA. The label includes usage instructions and storage information.*

FDA Label Image

Container Label Ndc 67184-0514-1 (Palonosetron 7)

Label for Palonosetron HCl Injection 0.25 mg/5 mL (0.05 mg/mL) by Qilu Pharmaceutical Co., Ltd. This intravenous injection comes in a 5 mL single-dose sterile vial. Storage instructions specify 20°C to 25°C (68°F to 77°F) and protection from light. Manufacturer information includes Qilu Pharmaceutical in Haikou, China, and Apotex Corp. in Weston, Florida, USA. The label includes a barcode and space for lot and expiration dates.*

FDA Label Image

Carton Label Ndc 67184-0514-1 (Palonosetron 8)

Palonosetron HCl Injection 0.25 mg/5 mL (0.05 mg/mL) carton label showing storage instructions, contents, and manufacturer details. The label indicates it is for intravenous injection only, provided in a 5 mL single-dose sterile vial. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. and labeled for Apotex Corp, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.